| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |